TCM
PRCT icon

TD Capital Management’s Procept Biorobotics PRCT Stock Holding History

TD Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11
Closed -$641 – 760
2025
Q1 		$641 Buy
+11
New +$751 ﹤0.01% 581

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

TD Capital Management's PRCT Position: Q2 2025 in Review

TD Capital Management sold out of Procept Biorobotics (PRCT) in Q2 2025, closing a stake of 11 shares — an estimated $641 sold.

TD Capital Management first reported a position in PRCT in Q1 2025 and held it in 1 quarter. The position peaked at $641 in Q1 2025. 271 funds tracked by Wall St. Rank hold PRCT as of Q2 2025.

  • TD Capital Management reported no remaining Procept Biorobotics position as of Q2 2025 after selling out during the quarter.
  • TD Capital Management sold 11 Procept Biorobotics shares in Q2 2025, an estimated $641.
  • TD Capital Management first reported a position in Procept Biorobotics in Q1 2025 and held it in 1 quarter.
  • TD Capital Management's Procept Biorobotics position peaked at $641 in Q1 2025.
  • 271 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2025.

Based on TD Capital Management's 13F filing for Q2 2025, filed 8 Aug 2025.